T
TrialScope
Global leader in clinical trial transparency and compliance
About TrialScope
TrialScope is a company that specializes in managing and disclosing clinical trial information. It operates in the healthcare and pharmaceutical industry, focusing on helping organizations meet regulatory requirements for clinical trial transparency. The company serves clients such as pharmaceutical companies, biotech firms, and other organizations involved in clinical research.
Read full description
TrialScope offers a comprehensive platform that organizes and monitors clinical trial data. This includes public registry data, trial milestones, and trial results. The platform helps clients manage their disclosure activities efficiently, ensuring they meet worldwide compliance deadlines. By providing clean, clear, and actionable data, TrialScope enables its clients to maintain complete and accurate records in a secure, cloud-based environment.
One of the standout features of TrialScope is its patient referral collective. This innovative solution connects trial sponsors with diverse clinical trial recruitment partners. The goal is to rapidly find, screen, and enroll highly qualified patients, thereby improving the speed and efficiency of clinical trials.
The company makes money through a subscription-based business model. Clients pay for access to TrialScope's platform and services, which include data management, compliance monitoring, and patient recruitment solutions. By offering these specialized services, TrialScope helps its clients save time and resources while ensuring they meet regulatory requirements.
In summary, TrialScope is a key player in the clinical trial transparency market, providing essential tools and services to help organizations manage and disclose trial information effectively.
Latest news
Press, funding announcements and product moves mentioning TrialScope.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| DEBT✓Debt | Sep 2018 | $4M | — | Undisclosed | — |
| DEBT✓Debt | May 2017 | $3.6M | — | Edison Partners · NewSpring Capital | — |
Growth signals
Latest recorded traffic for TrialScope is 3.6K monthly website visits, down 82% over the last three months. TrialScope's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Edison Partners
NewSpring Capital
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about TrialScope on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See TrialScope’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.





